ADHD is a neurodevelopmental disorder that has an unrecognised but high burden for individuals1,2,3 and society.4,5 ADHD is often under-diagnosed and under-treated.6
Until now, there has been a lack of data to illustrate the cost implication that the under-treatment of ADHD has had on health systems and societies.7 As a result, it has been difficult for policymakers to demonstrate the budget impact of investment in interventions to improve access to treatment for people living with ADHD.
To help address this, Takeda has commissioned a budget impact analysis model, based on work from Biederman et al8, which uses aggregated data to estimate the impact of untreated ADHD in 12 countries:
Read our ‘Attention on ADHD’ report, which uses a new budget impact analysis model commissioned by Takeda to show the cost of untreated ADHD and the value of increasing treatment rates to realise healthcare and social savings.
Download our infographic, which summarises the key findings from the report.
1. Katzman, M.A., Bilkey, T.S., Chokka, P.R. et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry 17, 302 (2017).
2. Gillberg, C., et al (2004). Co-existing disorders in ADHD -– implications for diagnosis and intervention. Eur Child Adolesc Psychiatry; 13 Suppl 1: I80–92
3. Biederman, J., et al (2019). Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 65(6), 784–789
4. Le, H., et al (2014). Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry; 23(7): 587–98.
5. Telford, C., et al (2013). Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol; 48(2): 337–44.
6. Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01600
7. Young, S., et al (2013). ADHD: making the invisible visible. An Expert White Paper on attention-deficit hyperactivity disorder (ADHD): policy solutions to address the societal impact, costs and long-term outcomes, in support of affected individuals. Available at: http://www.russellbarkley.org/factsheets/ADHD_MakingTheInvisibleVisible.pdf [Accessed January 2023]
8. Biederman, J., et al (2019). Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 65(6), 784–789
